-
1 Comment
Sundrug Co.,Ltd is currently in a long term downtrend where the price is trading 14.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Sundrug Co.,Ltd's total revenue rose by 11.4% to $164B since the same quarter in the previous year.
Its net income has increased by 32.7% to $7B since the same quarter in the previous year.
Based on the above factors, Sundrug Co.,Ltd gets an overall score of 3/5.
Industry | Pharmaceutical Retailers |
---|---|
Exchange | TSE |
CurrencyCode | JPY |
Sector | Healthcare |
ISIN | JP3336600006 |
Market Cap | 540B |
---|---|
PE Ratio | 17.88 |
Target Price | 5010 |
Dividend Yield | 2.8% |
Beta | 0.21 |
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. The company operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household products. The company was founded in 1957 and is headquartered in Fuchu, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 9989.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025